{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:59:35Z","timestamp":1760122775460},"reference-count":36,"publisher":"Guilford Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AIDS Education and Prevention"],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:p> HIV elimination by 2030 cannot occur without attention to substance use. It cuts across risk groups and affects sexual risk behavior, treatment adherence, and systemic processes such as immunity and inflammation. There continues to be often limited attention to non-injection drug use and the syndemic character of HIV and substance use. There is a need for a more comprehensive approach that addresses the multiple influences of substance use on HIV prevention and care, integrating this into evidence-based services and building on the successes of comprehensive Seek, Test, Treat, and Retain approaches to substantially reducing new HIV cases among drug users. <\/jats:p>","DOI":"10.1521\/aeap.2018.30.3.225","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T14:47:38Z","timestamp":1530629258000},"page":"225-231","source":"Crossref","is-referenced-by-count":5,"title":["Getting to Zero: We Can't Do It Without Addressing Substance Use"],"prefix":"10.1521","volume":"30","author":[{"given":"Richard A.","family":"Jenkins","sequence":"first","affiliation":[{"name":"National Institute on Drug Abuse, Bethesda, Maryland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"377","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-0913-0"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.278456"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1465-3362.2012.00423.x","volume":"32","author":"Brensilver M.","year":"2013","journal-title":"Drug and Alcohol Review"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2015.08.001"},{"key":"ref5","first-page":"273","volume":"55","author":"Centers for Disease Control and Prevention","year":"2006","journal-title":"Mortality & Morbidity Weekly Report"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61127-7"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.08.003"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(17)30375-3"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001039"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411243312106"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.05.018"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-014-0210-3"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2012.300810"},{"key":"ref17","volume-title":"Pathways of addiction: Opportunities in drug abuse research","author":"Institute of Medicine","year":"1996"},{"key":"ref18","volume-title":"Preventing mental, emotional, and behavioral disorders among young people: Progress and possibilities","author":"Institute of Medicine","year":"2009"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S109331"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000374"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s11121-013-0422-6"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2016.303627"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/wentk\/9780199764518.001.0001"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/01. aids.0000216374.61442.55"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000219"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(17)30373-X"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3109\/09687637.2012.743506"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2013.04.011"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/add.13338"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.20.1.21941"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02500.x"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1515195"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1525\/maq.2003.17.4.423"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1023\/A:1009516608672"},{"key":"ref36","volume-title":"Prevention gap report","author":"UNAIDS","year":"2016"},{"key":"ref37","volume-title":"Risk and transmission of HIV, HCV & HBV among stimulant drug users: A review of the evidence (A). Part 1\/5, methodology and summary","author":"United Nations Office on Drugs and Crime","year":"2017"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr1706626"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1515\/jdpa-2015-0011"},{"key":"ref40","volume-title":"Technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users","author":"World Health Organization","year":"2009"}],"container-title":["AIDS Education and Prevention"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T21:08:06Z","timestamp":1605820086000},"score":1,"resource":{"primary":{"URL":"https:\/\/guilfordjournals.com\/doi\/10.1521\/aeap.2018.30.3.225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.1521\/aeap.2018.30.3.225"],"URL":"https:\/\/doi.org\/10.1521\/aeap.2018.30.3.225","relation":{},"ISSN":["0899-9546"],"issn-type":[{"value":"0899-9546","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]}}}